MMJ Recs

OCTOBER 13, 2023

For patients seeking access to this valuable form of treatment, it’s essential to understand the complex web of regulations, legal requirements, and rights surrounding medical marijuana in the Golden State. California has long been a pioneer in the field of medical marijuana, and its MMJ laws have continued to evolve over the years.

Patients 52

Patients Law Cultivation Dispensary 52

Veriheal

AUGUST 22, 2022

Based on the details of a June 21 press release, the trials—which are taking place in Johannesburg—are the first ethically approved studies exploring the suitability and safety of using cannabis as a substitute for opioid pain relievers. . I don’t think it works for severe pain. Together, they work very well. ” Conclusion .

Clinical Trials 113

Clinical Trials Chronic Pain Hydroponic Strains 113

MMJ Recs

MARCH 2, 2024

Observing discretion in discussions regarding medical conditions and treatment enhances privacy and respect among patrons. Additionally, adhering to dispensary policies on product handling and consumption promotes harmony and safety. Q: What medical conditions qualify for medical marijuana use in Ohio?

Dispensary 52

Dispensary Patients Marijuana Education 52

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

NORML

MARCH 14, 2019

Enacted in 1986, the Federal Drug-Free Workplace Program made it a condition for employment that all civilian employees at executive branch agencies be prohibited from using federally illegal substances on or off duty. A recent American Legion poll found that one in five veterans use marijuana to alleviate a medical condition.

Chronic Pain 176

Chronic Pain Legislation Treatment State Laws 176

Peninsula Alternative Health

DECEMBER 14, 2017

Americans for Safe Access (ASA), a medical patient advocacy group, has an annual report on the proficiency of states’ medical cannabis programs, assigning each a letter grade. The state scores nearly perfect in ease of navigation, which means physicians can easily classify qualifying conditions, find caregivers, and charge reasonable fees.

Safety 63

Safety Access Dispensary Programs 63

Cannabis Law Report

JUNE 23, 2021

Across all patients, findings are reported in health-related quality of life as well as within specific conditions such as pain, anxiety, and palliative care. Patient Laura Drummond is prescribed medical cannabis for a persistent pain condition fibromyalgia. These patients also reported improved sleep and general quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., at the end of the 17 weeks of ganaxolone treatment.

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. As the largest cannabis patient advocacy group, their recommendations have helped me hone in on issues that impact patients and work to pass improvements to better their lives,” Rabb said.

Access 98

Access Law Patients Programs 98

Peninsula Alternative Health

DECEMBER 14, 2017

Americans for Safe Access (ASA), a medical patient advocacy group, has an annual report on the proficiency of states’ medical cannabis programs, assigning each a letter grade. The state scores nearly perfect in ease of navigation, which means physicians can easily classify qualifying conditions, find caregivers, and charge reasonable fees.

Safety 40

Safety Dispensary Access Patients 40

Cannabis Law Report

MAY 25, 2022

The plaintiff, Cristina Barbuto, used small quantities of medicinal marijuana as treatment for her Crohn’s disease. I am passionate about advocacy in all forms, and look forward to continue building on my experience in dispute resolution. Overview: Facts & Lower Courts. 10] In that case, there would be undue hardship. 13] p 471.

Policy 52

Policy Safety Law Patients 52

WeedAdvisor

JULY 3, 2019

Meanwhile migraine and arthritis sufferers both responded at a rate of 40% that they would use cannabis for treatment. Although there is plenty of evidence to support the efficacy of cannabis against a variety of conditions, there are other practical reasons why proponents want to see an end to prohibition.

Legalization 60

Legalization Marijuana Chronic Pain Recreational 60

Cannabis Law Report

APRIL 12, 2019

I use medical cannabis to treat ankylosing spondylitis and psoriatic arthritis among many other autoimmune conditions, mental health and the effects of chronic inflammation. We aim to continue to do more for the Canadian patients who choose to use medical cannabis as a treatment option. Patient advocacy is alive and well in Canada.

Access 45

Access Patients Marijuana Medicine 45

Cannabis Law Report

NOVEMBER 29, 2021

The social and economic conditions of people’s lives influence the risks of drug use, i.e., conditions that can be improved by policies that promote racial, economic, and social justice. Justification for the drug war is premised on the misconception that criminalized drugs are too dangerous to be used safely. [5]

Policy 52

Policy Decriminalization Treatment History 52

The Cannigma

DECEMBER 12, 2022

And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. Now, psychedelic research is booming. Are psychedelics safe?

History 119

History Microdosing Research and Development Clinical Trials 119

NORML

FEBRUARY 22, 2019

Regulators in Iowa added two new medical cannabis qualifying conditions to the current list, ulcerative colitis (effective immediately), and severe pediatric autism with self-injurious or aggressive behaviors (effective 4/2/19). Update : HB 2149 was approved by the Public Safety Committee on 2/20. AZ resident?

Legislation 177

Legislation Hemp Compliance Compliance 177

Cannabis Law Report

JUNE 26, 2019

I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis. Pain Foundation, the Florida Cannabis Advocacy Network, Americans for Safe Access, Drug Policy Alliance, and the Law Enforcement Action Partnership. . Cameron Vance, Ph.D.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

The Cannigma

DECEMBER 19, 2021

Since 2014, she has also served on the board of directors and in patient advocacy for the International Cystinuria Foundation, and wrote about the experience of her family on the foundation’s website. Cannabis for children isn’t a cure-all, but can it be considered as an option to treat some medical conditions (Shutterstock).

Treatment 135

Treatment Patients Dispensary Microdosing 135

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

SEPTEMBER 23, 2019

The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

The Cannigma

DECEMBER 22, 2021

At the moment, you said that they could potentially add more conditions. What conditions, or indications can doctors prescribe for in Israel at the moment? IR: Well, today, there is a closed list, basically, of conditions. It has the – you assume safety, at least to a certain level. We have autism and epilepsy.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

The Cannigma

DECEMBER 8, 2021

We’re often that lone voice over on the corner, looking out for consumers, looking out for their rights and for their safety. Then from there, you can get them to, “Okay, it can help with a variety of medical conditions.” EG: So, at that time, through your treatment, were you using cannabis? EG: Yeah, right. JMP: Always.

Access 81

Access Policy Patients Cannabis 81

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. Nikki’s story is deeply inspirational, and we are honored to have had her on the show.

Patients 83

Patients Compliance Compliance Cannabis 83

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Healing Advocacy Fund. in/carhart-harris-robin-19112542/ [link]. David Nutt. Drug Science.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

SEPTEMBER 22, 2019

Knowing Your Rights , provided by the national medical cannabis advocacy organization Americans for Safe Access, admonishes current cannabis consumers: Medical cannabis patients and their providers are vulnerable to federal and state raids, arrest, prosecution, and incarceration. PERSONAL RIGHTS.

Cannabis 45

Cannabis Access Patients Legalization 45